Correction to: Response to “Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes”

被引：0
|
作者：
Muhammad Rafay Shahzad Cheema
Satesh Kumar
机构：
[1] Allama Iqbal Medical College,
[2] Shaheed Mohtarma Benazir Bhutto Medical College,undefined
来源：
Acta Diabetologica | 2023年 / 60卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：717 / 717
相关论文
共 50 条
  • [41] Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes
    Dejgaard, Thomas F.
    Johansen, Nanna B.
    Frandsen, Christian S.
    Asmar, Ali
    Tarnow, Lise
    Knop, Filip K.
    Madsbad, Sten
    Andersen, Henrik U.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 734 - 738
  • [42] Comparison of Cardiovascular Risk Factors between Type 1 and Type 2 Diabetes
    Mosslemi, Mitra
    Park, Hannah L.
    Mclaren, Christine E.
    Wong, Nathan D.
    [J]. DIABETES, 2019, 68
  • [43] Cardiovascular disease risk factors in children with type 1 and type 2 diabetes
    Willi, S. M.
    Allegretto, R.
    He, W.
    Schneider, G.
    [J]. DIABETES, 2006, 55 : A414 - A414
  • [44] Cardiovascular Risk, Risk Knowledge, and Related Factors in Patients With Type 2 Diabetes
    Zehirlioglu, Lemye
    Mert, Hatice
    Sezgin, Dilek
    Ozpelit, Ebru
    [J]. CLINICAL NURSING RESEARCH, 2020, 29 (05) : 322 - 330
  • [45] Reducing the cardiovascular risk at patients with type 2 diabetes by controlling the risk factors
    Tudor, C.
    Jeberean, R. A.
    Buzas, R.
    Popescu, A.
    Ionita, M.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 346 - 346
  • [46] Cardiovascular risk factors in type 1 diabetes
    Syed, Ateeq A.
    Gangopadhyay, Kalyan
    Narendran, Parth
    [J]. DIABETES, 2007, 56 : A585 - A585
  • [47] Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus
    Kadoglou, N. P. E.
    Iliadis, F.
    Angelopoulou, N.
    Perrea, D.
    Liapis, C. D.
    Alevizos, M.
    [J]. DIABETIC MEDICINE, 2008, 25 (03) : 333 - 340
  • [48] Effects of exenatide vs insulin glargine on cardiovascular risk factors in subjects with type 2 diabetes
    Horton, E. S.
    Cohen, A.
    Gibson, H.
    Lamparello, B.
    Herzlinger, S.
    McFarland, L.
    [J]. DIABETOLOGIA, 2009, 52 : S298 - S299
  • [49] Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes mellitus
    Chu, NV
    Kim, DD
    Kong, APS
    Armstrong, DA
    Baxi, S
    Mudaliar, SR
    Reitz, R
    Reaven, PD
    Henry, RR
    [J]. DIABETES, 2000, 49 : A101 - A101
  • [50] Effects of improving insulin sensitivity on nontraditional cardiovascular risk factors in patients with type 2 diabetes
    Richard E. Pratley
    [J]. Current Diabetes Reports, 2003, 3 (1) : 63 - 64
12345